Establishment of Collagen: Hydroxyapatite/BMP-2 Mimetic Peptide Composites.
BMP-2 mimicry peptides
collagen/hydroxyapatite scaffolds
electrostatic binding on hydroxyapatite
quartz crystal microbalance
Journal
Materials (Basel, Switzerland)
ISSN: 1996-1944
Titre abrégé: Materials (Basel)
Pays: Switzerland
ID NLM: 101555929
Informations de publication
Date de publication:
07 Mar 2020
07 Mar 2020
Historique:
received:
11
02
2020
revised:
03
03
2020
accepted:
05
03
2020
entrez:
12
3
2020
pubmed:
12
3
2020
medline:
12
3
2020
Statut:
epublish
Résumé
Extensive efforts were undertaken to develop suitable biomaterials for tissue engineering (TE) applications. To facilitate clinical approval processes and ensure the success of TE applications, bioinspired concepts are currently focused on. Working on bone tissue engineering, we describe in the present study a method for biofunctionalization of collagen/hydroxyapatite composites with BMP-2 mimetic peptides. This approach is expected to be fundamentally transferable to other tissue engineering fields. A modified BMP-2 mimetic peptide containing a negatively charged poly-glutamic acid residue (E7 BMP-2 peptide) was used to bind positively charged hydroxyapatite (HA) particles by electrostatic attraction. Binding efficiency was biochemically detected to be on average 85% compared to 30% of BMP-2 peptide without E7 residue. By quartz crystal microbalance (QCM) analysis, we could demonstrate the time-dependent dissociation of the BMP-2 mimetic peptides and the stable binding of the E7 BMP-2 peptides on HA-coated quartz crystals. As shown by immunofluorescence staining, alkaline phosphatase expression is similar to that detected in jaw periosteal cells (JPCs) stimulated with the whole BMP-2 protein. Mineralization potential of JPCs in the presence of BMP-2 mimetic peptides was also shown to be at least similar or significantly higher when low peptide concentrations were used, as compared to JPCs cultured in the presence of recombinant BMP-2 controls. In the following, collagen/hydroxyapatite composite materials were prepared. By proliferation analysis, we detected a decrease in cell viability with increasing HA ratios. Therefore, we chose a collagen/hydroxyapatite ratio of 1:2, similar to the natural composition of bone. The following inclusion of E7 BMP-2 peptides within the composite material resulted in significantly elevated long-term JPC proliferation under osteogenic conditions. We conclude that our advanced approach for fast and cost-effective scaffold preparation and biofunctionalization is suitable for improved and prolonged JPC proliferation. Further studies should prove the functionality of composite scaffolds in vivo.
Identifiants
pubmed: 32155998
pii: ma13051203
doi: 10.3390/ma13051203
pmc: PMC7085073
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Bundesministerium für Forschung und Technologie
ID : KF2662003
Références
J Biomed Mater Res B Appl Biomater. 2019 Oct 1;:
pubmed: 31574204
Biomaterials. 2013 Jul;34(21):5059-69
pubmed: 23578562
J Biomed Mater Res A. 2020 Feb;108(2):201-211
pubmed: 31595677
Tissue Eng Part A. 2010 Aug;16(8):2467-73
pubmed: 20214455
Biomater Res. 2017 Jun 13;21:11
pubmed: 28620549
Acta Biomater. 2011 Jul;7(7):2969-76
pubmed: 21536155
Acta Biomater. 2011 Jul;7(7):2769-81
pubmed: 21440094
Biosens Bioelectron. 2018 Jan 15;99:593-602
pubmed: 28830033
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5140-5
pubmed: 15051872
Polymers (Basel). 2020 Jan 01;12(1):
pubmed: 31906327
Tissue Eng Part A. 2011 Apr;17(7-8):1083-97
pubmed: 21091326
Regen Biomater. 2019 Dec;6(6):361-371
pubmed: 31827888
Biochim Biophys Acta. 2003 Sep 23;1651(1-2):60-7
pubmed: 14499589
Materials (Basel). 2016 Nov 18;9(11):
pubmed: 28774058
Anal Bioanal Chem. 2014 May;406(14):3395-406
pubmed: 24705960
Bone. 2011 Apr 1;48(4):894-902
pubmed: 21147284
Biomed Mater. 2015 Dec 14;10(6):065019
pubmed: 26657659
Tissue Eng Part A. 2017 Apr;23(7-8):323-334
pubmed: 28051358
Health Technol Assess. 2007 Aug;11(30):1-150, iii-iv
pubmed: 17669279
Biomatter. 2014;4:e27664
pubmed: 24441389
Proc Inst Mech Eng H. 2017 Jun;231(6):555-564
pubmed: 28056713
J Biomed Mater Res B Appl Biomater. 2017 Nov;105(8):2315-2325
pubmed: 27504613
Nat Mater. 2012 Jul 01;11(8):724-33
pubmed: 22751179
Mater Sci Eng C Mater Biol Appl. 2016 Oct 1;67:267-275
pubmed: 27287122
Growth Factors. 2010 Feb;28(1):34-43
pubmed: 19835486
Biomed Mater. 2015 Aug 04;10(4):045018
pubmed: 26238604
Sci Rep. 2017 May 11;7(1):1778
pubmed: 28496103
Colloids Surf B Biointerfaces. 2017 Jun 1;154:160-170
pubmed: 28334693
Acta Biomater. 2016 May;36:132-42
pubmed: 27000551
Adv Funct Mater. 2011 Nov 22;21(22):4252-4262
pubmed: 26312060
Biomacromolecules. 2019 Jun 10;20(6):2350-2359
pubmed: 31059241
J Pharm Pharmacol. 2016 Feb;68(2):139-47
pubmed: 26727402
Mater Sci Eng C Mater Biol Appl. 2017 Aug 1;77:594-605
pubmed: 28532070
Biomacromolecules. 2014 Feb 10;15(2):445-55
pubmed: 24400664
J Biomed Mater Res A. 2016 Feb;104(2):533-43
pubmed: 26476098
Cell Stem Cell. 2008 Mar 6;2(3):205-13
pubmed: 18371446
ACS Appl Mater Interfaces. 2015 Oct 14;7(40):22618-29
pubmed: 26406396
Int J Biol Macromol. 2016 Dec;93(Pt A):314-321
pubmed: 27544436
J Biomater Appl. 2017 Aug;32(2):175-190
pubmed: 28618978
Ann Biomed Eng. 2017 Sep;45(9):2075-2087
pubmed: 28620768
Int Orthop. 2017 Sep;41(9):1899-1908
pubmed: 28616703
Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:78-88
pubmed: 27523999